Cambridge Investment Research Advisors, Inc. Precigen, Inc. Transaction History
Cambridge Investment Research Advisors, Inc.
- $26 Billion
- Q1 2024
A detailed history of Cambridge Investment Research Advisors, Inc. transactions in Precigen, Inc. stock. As of the latest transaction made, Cambridge Investment Research Advisors, Inc. holds 78,184 shares of PGEN stock, worth $114,930. This represents 0.0% of its overall portfolio holdings.
Number of Shares
78,184
Previous 69,384
12.68%
Holding current value
$114,930
Previous $93,000
21.51%
% of portfolio
0.0%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding PGEN
# of Institutions
142Shares Held
145MCall Options Held
208KPut Options Held
43.7K-
Third Security, LLC83.5MShares$123 Million73.5% of portfolio
-
Patient Capital Management, LLC Baltimore, MD17.5MShares$25.7 Million1.27% of portfolio
-
Black Rock Inc. New York, NY10.4MShares$15.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.77MShares$9.95 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA3.03MShares$4.46 Million0.0% of portfolio
About PRECIGEN, INC.
- Ticker PGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 208,150,000
- Market Cap $306M
- Description
- Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorpora...